Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04825587 · ClinicalTrials.gov registry record · NA

The Pediatric ALL Evaluation and Trial

A NA study of ACL Injury and ACL Tear, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT04825587 is a NA study of ACL Injury and ACL Tear that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 240 participants, below the 484-participant average among 12 other ACL Injury trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04825587, a NA study of ACL Injury and ACL Tear, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.

Conditions Studied

Interventions

  • PROCEDURE Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone.

Study Locations (1)

Illinois

  • Lurie Children's Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2021-04-28
Est. Completion 2028-04-01
Phase NA

What the Registry Record Tells You About NCT04825587

The ClinicalTrials.gov registry entry for NCT04825587 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 484-participant average among 12 other ACL Injury trials with a reported enrollment target (50% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with ACL Injury appearing as the primary indexed condition, and to 1 intervention - of which Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone. is the first listed.

NCT04825587 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04825587 about?

NCT04825587 is a clinical study titled "The Pediatric ALL Evaluation and Trial". The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.

What is the current status of trial NCT04825587?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2021-04-28. Estimated completion is 2028-04-01.

What conditions does trial NCT04825587 study?

This clinical trial studies the following conditions: ACL Injury, ACL Tear.

What interventions are being tested in trial NCT04825587?

The interventions under investigation include: Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone. (PROCEDURE).

Who is sponsoring clinical trial NCT04825587?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04825587 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ACL Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.